Physician profile
Ryan Powers
NPI 1104206309
$5,656.19
in general payments reported to CMS, 2019-2025
31 companies · $1,047 in 2025
The $1,047 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2021: $57.35 · 2022: $2,013 · 2023: $1,492 · 2024: $537 · 2025: $1,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,031 · Entertainment: $27.36 · Travel and Lodging: $17.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,031.19 |
| Entertainment | $27.36 |
| Travel and Lodging | $17.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,849.65 | 2021-2024 | Urolift |
| Procept Biorobotics Corporation | $667.05 | 2022-2025 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $400.58 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $341.89 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Rezum Generator |
| Sumitomo Pharma America, INC. | $309.61 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $278.06 | 2022-2025 | Jelmyto |
| Coloplast Corp | $158.27 | 2022-2025 | Titan, Speedicath |
| Pfizer INC. | $157.61 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $143.47 | 2024-2025 | |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Travere Therapeutics, INC. | $130.30 | 2019 | |
| Ferring Pharmaceuticals INC. | $127.10 | 2024-2025 | Adstiladrin |
| Intuitive Surgical, INC. | $111.18 | 2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $109.97 | 2019-2025 | Xtandi |
| Axonics, INC. | $109.30 | 2023 | Bulkamid, Axonics |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $100.10 | 2023-2025 | Posluma |
| Myriad Genetic Laboratories, INC. | $75.08 | 2024-2025 | Prolaris |
| Olympus America INC. | $71.59 | 2023-2025 | Itind System |
| Conmed Corporation | $66.57 | 2023-2025 | Airseal |
| Abbvie INC. | $60.96 | 2024-2025 | |
| Provepharm INC. | $46.77 | 2023-2025 | Bludigo |
| Ambu INC. | $39.98 | 2023 | |
| Antares Pharma, INC. | $23.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.55 | 2025 | |
| 180 Medical, INC. | $20.59 | 2025 | |
| Smith+Nephew, INC. | $18.30 | 2023 | Pico |
| Accord Healthcare, INC. | $17.62 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $17.33 | 2023 | Seglentis |
| Photocure INC | $15.40 | 2023 | Cysview |
| C. R. Bard, INC. & Subsidiaries | $14.91 | 2025 | Aptra |
| Acacia Pharma INC | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.